Latest News about CRSP
Recent news which mentions CRSP
3 No-Brainer Stocks to Buy in June
June 10, 2023
From Motley Fool
Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application
June 09, 2023
From Benzinga
Vertex/CRISPR Partnered Cell Therapy Shows Encouraging In Sickle Cell Disease, Thalassemia Patients
June 09, 2023
From Benzinga
From InvestorPlace
TGT Stock Alert: Have Target’s Sales Numbers Peaked?
June 09, 2023
From InvestorPlace
Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?
June 09, 2023
From InvestorPlace
Wall Street Loves These 3 Growth Stocks -- Should You?
June 09, 2023
From Motley Fool
Can This Gene-Editing Stock Deliver 10X Returns?
June 08, 2023
From Motley Fool
From Motley Fool
From InvestorPlace
Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?
June 06, 2023
From InvestorPlace
3 Top Healthcare Stocks to Buy for June
June 06, 2023
From Motley Fool
CRISPR Therapeutics: A Galaxy's Worth of Deep Value
May 31, 2023
From Motley Fool
3 Disruptors I Love Right Now
May 30, 2023
From Motley Fool
From Motley Fool
3 No-Brainer Stocks to Buy for Under $100 Right Now
May 27, 2023
From Motley Fool
2 Supercharged Stocks to Buy With $100
May 27, 2023
From Motley Fool
2 Top Trends to Invest $5,000 in Right Now
May 25, 2023
From Motley Fool
From Motley Fool
Cathie Wood Just Sold CRISPR Therapeutics Stock. Here's Why You Should Consider Buying It
May 21, 2023
Tickers
CRSP
From Motley Fool
From Motley Fool
From InvestorPlace
2 Stocks You'll Be Glad You Bought at These Prices
May 17, 2023
From Motley Fool
From Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
May 13, 2023
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free